Publication:
Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta

Placeholder

Departments

School / College / Institute

Organizational Unit
Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU Authors

Co-Authors

Etzion, Ohad
Hamid, Saeed Sadiq
Asselah, Tarik
Gherlan, George Sebastian
Turcanu, Adela
Petrivna, Tsarynna
Weissfeld, Lisa
Choong, Ingrid
Hislop, Colin
Apelian, David

Publication Date

Language

Embargo Status

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Source

Publisher

Elsevier

Subject

Gastroenterology and hepatology

Citation

Has Part

Source

Journal of Hepatology

Book Series Title

Edition

DOI

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

7

Views

0

Downloads